Range
4.84 - 5.19
Vol / Avg.
762.9K/496.4K
Div / Yield
-
52 Wk
3.76 - 9.08
Mkt Cap
600.3M
Payout Ratio
-
Open
5.07
P/E
-
EPS
-0.34
Shares
123.8M
Outstanding
123.8M
Total Float
-
load more
Sector: Health Care.Industry: Biotechnology
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.320-0.310 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ORTXOrchard Therapeutics0%600.3M

Orchard Therapeutics Frequently Asked Questions

Q

How do I buy Orchard Therapeutics (ORTX) stock?

A

You can purchase shares of Orchard Therapeutics (NASDAQ: ORTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Orchard Therapeutics's (ORTX) competitors?

Q

What is the target price for Orchard Therapeutics (ORTX) stock?

A

The latest price target for Orchard Therapeutics (NASDAQ: ORTX) was reported by JP Morgan on March 2, 2021. The analyst firm set a price target for 15.00 expecting ORTX to rise to within 12 months (a possible 209.28% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Orchard Therapeutics (ORTX)?

A

The stock price for Orchard Therapeutics (NASDAQ: ORTX) is $4.85 last updated Today at 8:00:02 PM.

Q

Does Orchard Therapeutics (ORTX) pay a dividend?

A

There are no upcoming dividends for Orchard Therapeutics.

Q

When is Orchard Therapeutics (NASDAQ:ORTX) reporting earnings?

A
Orchard Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Orchard Therapeutics (ORTX) going to split?

A

There is no upcoming split for Orchard Therapeutics.

Q

What sector and industry does Orchard Therapeutics (ORTX) operate in?

A

Orchard Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.